[HTML][HTML] Hemophilia B gene therapy with a high-specific-activity factor IX variant
LA George, SK Sullivan, A Giermasz… - … England Journal of …, 2017 - Mass Medical Soc
Background The prevention of bleeding with adequately sustained levels of clotting factor,
after a single therapeutic intervention and without the need for further medical intervention …
after a single therapeutic intervention and without the need for further medical intervention …
[PDF][PDF] Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
L George, K Sullivan, A Giermasz - New England Journal of Medicine, 2017 - nccbb.net
The Zika epidemic, with its associated fetal morbidity, resulted in a wide variety of
emergency responses ranging from mosquito control initiatives, to blood donor screening in …
emergency responses ranging from mosquito control initiatives, to blood donor screening in …
[PDF][PDF] Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
LA George, SK Sullivan, A Giermasz, JEJ Rasko… - N Engl J Med, 2017 - academia.edu
The new england journal of medicine Page 1 The new england journal of medicine n engl j
med 377;23 nejm.org December 7, 2017 2215 established in 1812 December 7, 2017 vol. 377 …
med 377;23 nejm.org December 7, 2017 2215 established in 1812 December 7, 2017 vol. 377 …
[引用][C] Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
LA George, SK Sullivan, A Giermasz… - New England Journal …, 2017 - cir.nii.ac.jp
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
[HTML][HTML] Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
LA George, SK Sullivan, A Giermasz… - The New England …, 2017 - ncbi.nlm.nih.gov
BACKGROUND The prevention of bleeding with adequately sustained levels of clotting
factor, after a single therapeutic intervention and without the need for further medical …
factor, after a single therapeutic intervention and without the need for further medical …
[PDF][PDF] Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
LA George, SK Sullivan, A Giermasz, JEJ Rasko… - N Engl J …, 2017 - researchgate.net
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant Page 1 The new
england journal of medicine n engl j med 377;23 nejm.org December 7, 2017 2215 …
england journal of medicine n engl j med 377;23 nejm.org December 7, 2017 2215 …
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
LA George, SK Sullivan, A Giermasz… - The New England …, 2017 - europepmc.org
Background The prevention of bleeding with adequately sustained levels of clotting factor,
after a single therapeutic intervention and without the need for further medical intervention …
after a single therapeutic intervention and without the need for further medical intervention …
[PDF][PDF] Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
LA George, SK Sullivan, A Giermasz, JEJ Rasko… - N Engl J …, 2017 - stage.labcorp.com
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant Page 1 The new
england journal of medicine n engl j med 377;23 nejm.org December 7, 2017 2215 …
england journal of medicine n engl j med 377;23 nejm.org December 7, 2017 2215 …
[PDF][PDF] Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
LA George, SK Sullivan, A Giermasz, JEJ Rasko… - N Engl J …, 2017 - med.upenn.edu
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant Page 1 The new
england journal of medicine n engl j med 377;23 nejm.org December 7, 2017 2215 …
england journal of medicine n engl j med 377;23 nejm.org December 7, 2017 2215 …
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
LA George, SK Sullivan, A Giermasz… - The New England …, 2017 - pubmed.ncbi.nlm.nih.gov
Background The prevention of bleeding with adequately sustained levels of clotting factor,
after a single therapeutic intervention and without the need for further medical intervention …
after a single therapeutic intervention and without the need for further medical intervention …